All assets

Sanofi (SNY)

equity · Nasdaq

Last 30 days
2 mentions · 2 episodes
Last 90 days
2 mentions · 2 episodes

Stance shows how speakers talked about the asset, not investment advice. Figures and views are speaker claims; verify them against the original audio and primary sources.

Mentions over time

bullishbearishmixedneutral
2026-08-24
2026-08-31
2026-09-07
2026-09-14
2026-09-21
2026-09-28
2026-10-05
2026-10-12
2026-10-19
2026-10-26
2026-11-02
2026-11-09
2
2026-11-16

Recent mentions

  1. The East-West Bio Brief ·

    Daily, Sat 14 Nov: FDA decision day for ivonescimab, Akeso's lung cancer bispecific

    Ning neutral

    “Together with a $50 million private placement from Sanofi, it expects to raise $225 million before costs, according to its company press release.”

    Listen at 8:27Original audio

  2. The East-West Bio Brief ·

    Daily, Thu 12 Nov: A Shanghai pill wins FDA approval, after China said yes first

    Unidentified speaker (speaker_0) neutral

    “And Sanofi has agreed to buy $50 million of shares in a private placement alongside the offering.”

    Listen at 6:57Original audio

Claims about this asset

  • Unidentified speaker (UNKNOWN) says: Recursion has partnerships with Roche, Genentec, and Sanofi.

    How to verify: Search Recursion Pharmaceuticals' investor relations website or SEC filings (e.g., 8-K or 10-K) for partnership agreements with Roche, Genentec, and Sanofi. For recent events, verify 2026-08-15 through 2026-11-15. Use another period only when the speaker explicitly names it.

    Recursion Pharmaceuticals: Can AI Turn Biology Into Medicines? - $RXRXPrimary source

Often mentioned with

    No other assets in the same segments yet.

    Podcasts that cover it most

    1. The East-West Bio Brief · 2 mentions